Atlas Trials

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD

Clinical trial NCT06714526 · RECRUITING

Trial details

NCT number
NCT06714526
Sponsor
Sunnybrook Health Sciences Centre
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Intracranial Atherosclerosis
Start date
2025-10-07
Primary completion
2027-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.